Pfizer Sues Dexcel Pharmaceuticals Alleging Patent Infringement
https://pharmanewsintel.com/news/pfizer-sues-dexcel-pharmaceuticals-alleging-patent-infringement
WEBAugust 17, 2023 - Early this week, Pfizer and the Scripps Research Institute announced that they would be suing Israel’s Dexcel Pharma for patent infringement affecting Vyndamax, a drug that already generated $818 million in revenue in 2023. In a July letter to Pfizer, Dexcel shared that it had filed an abbreviated new drug application (ANDA ...
DA: 80 PA: 89 MOZ Rank: 22